SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?


To: diaperdaddy who wrote (63018)2/28/2025 8:34:25 AM
From: erickerickson3 Recommendations

Recommended By
jargonweary
luckydog88
rodneyh07

  Respond to of 63305
 
re: Joining the SAVA lawsuit.

Daddy:

I have the exact same reaction to these as you do. And the same lack of evidence to support my cynicism. That said, much of my cynicism is fueled by the utter predictability of these lawsuits whenever, say, the PPS drops. This case certainly has potential to have more substance behind the complaints.

Here's an interesting breakdown (unresearched): dwt.com. A couple of extracts:

"It pays to challenge the adequacy of a securities class action at the pleading stage. From 2013 through 2022, motions to dismiss were filed in 96 percent of federal securities class actions. Plaintiffs voluntarily dismissed the action 18 percent of the time and settled 8 percent of the time. Courts ruled in 73 percent of cases, dismissing the case in whole or in part 80 percent of the time: 54 percent without prejudice, 7 percent with prejudice; 19 percent were partially granted. Courts denied motions to dismiss in their entirety only 20 percent of the time."

"Average and median settlement values increased by more than 50 percent compared to 2021. The average settlement value increased by over 70 percent to $38 million, and the median settlement value increased by over 50 percent to $13 million. However, 2021 was a relatively low year."

So, first of all it's likely the case will be dismissed. Even if it's settled, and taking the $38M number as the settlement, after the lawyer's fees I don't think it's very lucrative for the smaller shareholders. I suppose if I'd owned, say, 100K shares a settlement could be worth it, assuming all I had to do was sign my name. But I didn't even have close to that number.

That said, IMO most of the lawsuits are frivolous, witness the unending number from IMMU. This case may well be different and actually result in a settlement. If it does, where would the money come from? Blood from a turnip...

All of which means that I'm not interested as the payback is minuscule compared to what I lost, it'll take forever to resolve etc. Better just to learn a few lessons and move on. Fortunately, SAVA was about 2% of my portfolio, so I can be philosophical about it, unlike what would have been the case if something similar had happened to IMMU.